David Jollow to Primaquine
This is a "connection" page, showing publications David Jollow has written about Primaquine.
Connection Strength
0.507
-
Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline. J Pharmacol Exp Ther. 2001 May; 297(2):509-15.
Score: 0.202
-
Primaquine-induced hemolytic anemia: role of splenic macrophages in the fate of 5-hydroxyprimaquine-treated rat erythrocytes. J Pharmacol Exp Ther. 2005 Dec; 315(3):980-6.
Score: 0.068
-
Primaquine-induced hemolytic anemia: role of membrane lipid peroxidation and cytoskeletal protein alterations in the hemotoxicity of 5-hydroxyprimaquine. J Pharmacol Exp Ther. 2005 Aug; 314(2):838-45.
Score: 0.067
-
Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine. J Pharmacol Exp Ther. 2004 Apr; 309(1):79-85.
Score: 0.061
-
Primaquine-induced hemolytic anemia: effect of 6-methoxy-8-hydroxylaminoquinoline on rat erythrocyte sulfhydryl status, membrane lipids, cytoskeletal proteins, and morphology. J Pharmacol Exp Ther. 2002 Oct; 303(1):141-8.
Score: 0.056
-
Comparative pharmacokinetics and tissue distribution of primaquine enantiomers in mice. Malar J. 2022 Feb 05; 21(1):33.
Score: 0.053